Towards biomarker-based diagnosis of Parkinson disease.
Eduardo Tolosa, Werner Poewe, Alastair J Noyce...
https://pubmed.ncbi.nlm.nih.gov/41688680/Actively Recruiting
Led by Radboud University Medical Center · Updated on 2026-08-27
110
Participants Needed
1
Research Sites
N/A
Total Duration
This research aims to evaluate the feasibility of using a smartphone app to increase the amount and intensity of physical activity in people with isolated Rapid Eye Movement REM sleep behavior disorder iRBD, who are at high risk of developing Parkinsons disease or related neurodegenerative conditions. The study focuses on how a remotely delivered intervention might support long-term exercise over 24 months to potentially slow disease progression during the prodromal stage. It also explores the potential for digital assessments and biomarkers to monitor disease features and progression. Participants will be randomly assigned to one of two groups that differ in the physical activity goals they are encouraged to reach using the Slow-SPEED smartphone app. This app provides motivation and feedback to increase daily step counts and minutes of moderate to vigorous physical activity based on each persons baseline. The intervention lasts for two years, during which physical activity and heart rate are continuously monitored using a Fitbit smartwatch. The study also collects blood samples and brain imaging data to develop a composite score estimating prodromal disease load. Throughout the study, participants will be assessed remotely via digital tools, including smartphone apps and wearable devices, to measure physical activity, motor and non-motor symptoms, fitness, sleep patterns, cognition, and quality of life at various points up to 104 weeks. Blood biomarkers and brain imaging will be collected at baseline and follow-up to track disease progression. Researchers will analyze compliance, retention, and usability data, aiming to understand the long-term effects and feasibility of this remote exercise intervention in people with iRBD.
CONDITIONS
Slow-SPEED-NL: Slowing Parkinson's Early Through Exercise Dosage-Netherlands
T
Thomas Oosterhof, MSc
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Radboud University Medical Center
Lead Sponsor
Stichting ParkinsonNL
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 screening visit
Duration - 24 months
Participants use the Slow-SPEED smartphone app to increase their daily step count and exercise intensity over a 24-month period. Physical activity is remotely monitored using a Fitbit smartwatch. The app provides motivation and feedback to reach personalized activity goals.
Regular remote assessments and data collection via smartphone and smartwatch
Duration - Up to 24 months during and after intervention
Participants complete periodic remote evaluations including questionnaires, cognitive and motor tests, blood sample collection, and brain imaging to monitor disease progression and intervention effects.
Scheduled remote assessments and in-person visits for blood sampling and imaging at baseline and follow-up
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Eduardo Tolosa, Werner Poewe, Alastair J Noyce...
https://pubmed.ncbi.nlm.nih.gov/41688680/Thomas H Oosterhof, Eleanor Mitchell, Alberto Ascherio...
https://pubmed.ncbi.nlm.nih.gov/42448717/Radboud University Medical Center
Lead Sponsor
Stichting ParkinsonNL
Collaborating Sponsor